GC-Rise Pharmaceutical To Launch Remifemin In China
This article was originally published in PharmAsia News
Executive Summary
GC-Rise Pharmaceutical, a firm focusing on women's health, will launch Remifemin in the country soon. The drug, made from the extract of the medicinal plant black cohosh for treating menopausal symptoms, is produced by German company Schaper & Brümmer. Remifemin has been used worldwide for more than 50 years; its effectiveness and reliability have also been proven by strict trials in several Chinese authoritative clinical centers. Patients who are not candidates for hormone replacement therapy or who have concerns about the therapy's safety will have more choice after Remifemin enters the market. (Click here for more - Chinese Language)